# Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery

> **NCT03702621** · PHASE3 · COMPLETED · sponsor: **Indiana University** · enrollment: 90 (actual)

## Conditions studied

- Colorectal Surgery

## Interventions

- **DRUG:** liposomal Bupivacaine
- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT03702621
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702621, "Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03702621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*